國際制藥集團施維雅(ya)(Servier)和谷(gu)(gu)歌云(yun)宣布(bu)擴大(da)為(wei)期五年的合作(zuo)伙伴關(guan)系，專注(zhu)于(yu)使用AI和生(sheng)成式AI (gen AI)來(lai)加速為(wei)患者研發(R&D)創新治療解決方案。施維雅(ya)將(jiang)人(ren)(ren)工(gong)(gong)智能視(shi)為(wei)其數(shu)字化(hua)轉型(xing)之旅的關(guan)鍵(jian)要素，并已(yi)開始為(wei)集團員工(gong)(gong)提供(gong)一套基(ji)于(yu)谷(gu)(gu)歌和谷(gu)(gu)歌云(yun)生(sheng)成人(ren)(ren)工(gong)(gong)智能技(ji)(ji)術的工(gong)(gong)具，包括Gemini大(da)型(xing)語言模型(xing)。谷(gu)(gu)歌云(yun)將(jiang)支持施維雅(ya)團隊在整(zheng)個價(jia)值鏈(lian)中整(zheng)合各種人(ren)(ren)工(gong)(gong)智能技(ji)(ji)術，同時(shi)確(que)保生(sheng)成數(shu)據的安全性和保密性。（美通(tong)社）
